BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: €0.02 M
• Last 3 months FTD volume: €0.58 M
• Last 12 months FTD volume: €4.51 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	€0.92 M	€16.71 M	🇺🇸 USA
Sarepta Therapeutics SRPT	€2.3 M	€22.38 M	🇺🇸 USA
NanoViricides NNVC	€1.96 M	€6.74 M	🇺🇸 USA
Novavax NVAX	€15.95 M	€65.06 M	🇺🇸 USA
Gilead Sciences GILD	€60.15 M	€0.26 B	🇺🇸 USA
Celldex Therapeutics CLDX	€7.65 M	€11.96 M	🇺🇸 USA
GlaxoSmithKline GSK	€72.01 M	€0.40 B	🇬🇧 UK
Emergent BioSolutions EBS	€1.89 M	€4.32 M	🇺🇸 USA
Cel-Sci CVM	N/A	€0.94 M	🇺🇸 USA